In short
Around 70% of the world's cancer deaths now occur in low- and middle-income countries. The cancers are the same as in wealthy nations, but survival is far lower because diagnosis comes late and surgery, chemotherapy and radiotherapy are scarce or unaffordable. Closing the gap means getting existing, proven treatment to those who cannot reach it.
Cancer is often thought of as a disease of wealthy, ageing societies. In reality, the majority of cancer deaths now happen in low- and middle-income countries — and the gap in survival between rich and poor nations is stark.
What makes this so painful is that the difference usually has nothing to do with the cancer itself. A breast or cervical cancer that is highly survivable in the UK can be a death sentence elsewhere — not because the tumour behaves differently, but because of when it is found and whether treatment can be reached and afforded.
This guide explains why survival is so much lower in developing countries, the barriers behind it, and what it takes to close the gap.
Why survival is so much lower
In high-income countries, decades of investment in screening, diagnosis and treatment mean many cancers are caught early and treated effectively. In many low- and middle-income countries, those systems are thin or absent, so patients are diagnosed late — often when the cancer has already spread and is far harder to treat.
The World Health Organization reports that around 70% of cancer deaths occur in low- and middle-income countries, and that the availability of treatment varies enormously between richer and poorer nations. The result is that the same diagnosis can carry a very different prognosis depending only on where a person lives.
The barriers: late diagnosis, cost and access
Several barriers stack up against patients in poorer countries:
- Late diagnosis — limited screening and awareness mean cancer is often found at an advanced stage
- Distance and scarcity — specialist cancer centres, oncologists and radiotherapy machines are few and concentrated in big cities
- Cost — where treatment exists it is often paid out of pocket, putting it beyond reach for poor families
- Interruption — some patients start treatment but cannot afford to complete it, which undermines its effectiveness
Help a patient afford cancer care
Gifts go to the Cancer Emergency Appeal’s wider fund for patients who cannot pay. They do not buy a guaranteed treatment or result.
Donate to cancer careWhat closing the gap looks like
Because the treatments already exist, closing the gap is largely about access: earlier diagnosis, more trained oncologists and equipment, and — crucially — removing the financial barrier so that poor patients can actually receive and finish treatment. The radiotherapy guide explains the global machine gap.
World Aid Network's cancer programme targets exactly this gap. It funds cancer treatment — surgery, chemotherapy, radiotherapy and diagnostics — for poor patients in Pakistan, Indonesia and Malaysia, delivered by locally-licensed oncologists in registered hospitals, so that a treatable cancer is not left untreated for want of money.
Key takeaways
- Around 70% of the world's cancer deaths now occur in low- and middle-income countries.
- Lower survival is driven by late diagnosis, scarce specialist care, and unaffordable treatment — not by different cancers.
- Existing, proven treatments could save many lives if they could be reached and afforded.
- Closing the gap is mainly about access, not new science.
- World Aid Network funds treatment for poor patients through locally-licensed oncologists to close this gap.
Help close the cancer survival gap
The same cancer, a very different outcome — decided by whether treatment can be reached and afforded. World Aid Network funds treatment for poor patients through locally-licensed oncologists. Donate today.
Frequently asked questions
Why is cancer survival lower in poor countries?
Mainly because cancer is diagnosed late and treatment is scarce or unaffordable — not because the cancers differ. Limited screening means many cancers are found after they have spread, specialist centres and radiotherapy are few, and treatment is often paid out of pocket, putting it beyond reach. The World Health Organization reports around 70% of cancer deaths occur in low- and middle-income countries.
Are the cancers in developing countries different?
The cancers themselves are broadly the same. What differs is the outcome: a cancer that is routinely survivable in a wealthy country can be fatal elsewhere because of late diagnosis and lack of access to treatment. The pattern of which cancers are most common can vary by region, but the core treatments are the same worldwide.
What treatments are hard to access in low-income countries?
Surgery, chemotherapy and radiotherapy — the mainstays of cancer treatment — are all harder to access. Radiotherapy in particular requires expensive machines and trained staff that many countries have far too few of, and chemotherapy drugs and diagnostics are often unaffordable for poor patients.
How can cancer survival be improved in developing countries?
By improving access to what already works: earlier diagnosis, more trained oncologists and equipment, and removing the financial barrier so patients can receive and complete treatment. Funding treatment for those who cannot pay is one of the most direct ways to save lives now.
How does World Aid Network help?
World Aid Network funds cancer treatment — surgery, chemotherapy, radiotherapy and diagnostics — for poor patients in Pakistan, Indonesia and Malaysia, delivered by locally-licensed oncologists in registered hospitals. This directly removes the cost barrier that leaves treatable cancers untreated.
Editorial summary of published sources. A named oncology clinician has not signed off this guide. Use it to prepare questions for your healthcare team, not to diagnose symptoms or choose treatment. Editorial responsibility: Kaiser Khan.
What are the sources for this guide?
Follow the original guidance for its evidence, dates and limitations. General background references are not a clinical review of this page.
- NHS — Cancer
- World Health Organization — Cancer fact sheet
- World Health Organization — Global initiatives on cancer treatment access